Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Plasma [bdsu]
Myeloperoxidase level [lbpr]
Affecting [ftcn]
Resistance [menp]
Oxidation [moft]
LDL Particle Size [lbpr]
Objective [inpr]
This [euka]
Study [mnob]
Design [acty]
To [qlco]
investigate [ftcn]
effects [qlco]
Different [qlco]
therapeutic range [lbtr]
Doses [qnco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Alone [qnco]
Combination [qlco]
Progesterone [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Plasma lipoprotein levels [lbpr]
Three [qnco]
Parameters [fndg]
Resistance [menp]
Oxidation [moft]
Copper [bacs, elii, phsu]
LDL Particle Size [lbpr]
Myeloperoxidase level [lbpr]
Design [acty]
Five [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Received [qlco]
Two [qnco]
Consecutive [qlco]
month [tmco]
Doses [qnco]
transdermal estrogen [horm, phsu, strd]
Patch [fndg]
Assigned [ftcn]
To [qlco]
Receive [qlco]
month [tmco]
treatment [ftcn]
Patch [fndg]
Patch [fndg]
Combined [qlco]
Progesterone [horm, phsu, strd]
mg day [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
mg day [qnco]
Last [qlco]
days [tmco]
Result [ftcn]
Transdermal [ftcn]
Alone [qnco]
Transdermal [ftcn]
Plus [qlco]
Progestagen [horm, phsu, strd]
Modified [ftcn]
Lipoprotein [aapp, bacs]
Profile [lbpr]
Resistance [menp]
Oxidation [moft]
LDL Particle Size [lbpr]
Treatments [topp]
Reduced [qlco]
Myeloperoxidase level [lbpr]
Protein [aapp, bacs]
Conclusions [idcn]
Different [qlco]
Dosages [qnco]
Transdermal [ftcn]
therapeutic range [lbtr]
effective [qlco]
Reducing [qlco]
Myeloperoxidase level [lbpr]
Protein [aapp, bacs]
Effect [qlco]
Addition [ftcn]
Progesterone [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Sequential [idcn]
